Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International stock ...

Updated Phase 2 CRDF-004 data to be presented during ASCO 2026 rapid oral session on June 2, 2026; investor webcast scheduled for June 3, 2026 at 8:30 am ET to review the dataSAN DIEGO, Calif., May 21 ...

Therapeutics, a clinical-stage biotechnology company, today announced preliminary safety and efficacy data from its ongoing, first-in-human Phase 1/2 trial of PARG inhibitor ETX-19477. These data will ...

The UC Davis Mike and Renée Child Institute for Innovation and Entrepreneurship awarded almost $100,000 in grants and startup ...

Framing agriculture as a frontline issue of national security, Sen. Jim Banks (R-IN) has introduced legislation that would ...

NeuroDex is developing a blood-based biomarker research platform designed to study molecular signals associated with ...

On this week’s episode of “The Readout LOUD,” the hosts discuss STAT's Breakthrough Summit West, where powerful leaders from ...

Biotech investors are once again rotating aggressively into clinical-stage growth stories as a fresh wave of capital ...

India-founded Wadhwani Foundation and the U.S.-based Gates Foundation have signed a partnership to expand translational ...

Market News UpdatesNews Commentary - The market for peptide-based health and performance products has been growing fast as more consumers focus on fitness, recovery, longevity, weight management, and ...

Round led by PXN Ventures, with additional funding from existing investors IQ Capital and Northern Gritstone * Company uses quantum physics, AI m ...

Theromics Inc., a biotechnology company advancing the field of ablation therapeutics for minimally invasive cancer treatment, today announced the appointment of Andrew C. Zeringue as Chief Executive ...